Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 546941 - 546960 out of 553680 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L04AX03) methotrexate | RASUVO 20MG/0.40ML INJ | 4X0.40ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | MedexusPharma,Inc. |
| USA | (L04AX03) methotrexate | RASUVO 20MG/0.45ML INJ | 4X0.45ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | MedexusPharma,Inc. |
| USA | (L04AX03) methotrexate | RASUVO 25MG/0.50ML INJ | 4X0.50ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | MedexusPharma,Inc. |
| USA | (L04AX03) methotrexate | RASUVO 30MG/0.60ML INJ | 4X0.60ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | MedexusPharma,Inc. |
| USA | (L04AX03) methotrexate | RASUVO 7.5MG/0.15ML INJ | 4X0.15ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | MedexusPharma,Inc. |
| USA | (L04AX03) methotrexate | XATMEP 2.5MG/ML SOLN,ORAL | 120ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AzurityPharmaceuticals,Inc. |
| USA | (L04AX03) methotrexate | XATMEP 2.5MG/ML SOLN,ORAL | 60ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AzurityPharmaceuticals,Inc. |
| USA | (L04AX03) methotrexate | XATMEP 2.5MG/ML SOLN,ORAL | 120ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AzurityPharmaceuticals,Inc. |
| USA | (L04AX03) methotrexate | XATMEP 2.5MG/ML SOLN,ORAL | 60ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AzurityPharmaceuticals,Inc. |
| USA | (L04AX03) methotrexate | JYLAMVO 2MG/ML SOLN,ORAL | 60ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Psoriatic;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Psoriasis;Arthritis, Rheumatoid;Arthritis | ShorlaOncology |
| USA | (L04AX04) lenalidomide (adm: O) | REVLIMID 10MG CAP | 100 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma;Lymphoma, Mantle-Cell;Myelodysplastic Syndromes | Bristol-MyersSquibbCompany |
| USA | (L04AX04) lenalidomide (adm: O) | REVLIMID 10MG CAP | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma;Lymphoma, Mantle-Cell;Myelodysplastic Syndromes | Bristol-MyersSquibbCompany |
| USA | (L04AX04) lenalidomide (adm: O) | REVLIMID 10MG CAP | 100 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma;Lymphoma, Mantle-Cell;Myelodysplastic Syndromes | Bristol-MyersSquibbCompany |
| USA | (L04AX04) lenalidomide (adm: O) | REVLIMID 10MG CAP | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma;Lymphoma, Mantle-Cell;Myelodysplastic Syndromes | Bristol-MyersSquibbCompany |
| USA | (L04AX04) lenalidomide (adm: O) | REVLIMID 15MG CAP | 100 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma;Lymphoma, Mantle-Cell;Myelodysplastic Syndromes | Bristol-MyersSquibbCompany |
| USA | (L04AX04) lenalidomide (adm: O) | REVLIMID 15MG CAP | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma;Lymphoma, Mantle-Cell;Myelodysplastic Syndromes | Bristol-MyersSquibbCompany |
| USA | (L04AX04) lenalidomide (adm: O) | REVLIMID 15MG CAP | 100 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma;Lymphoma, Mantle-Cell;Myelodysplastic Syndromes | Bristol-MyersSquibbCompany |
| USA | (L04AX04) lenalidomide (adm: O) | REVLIMID 15MG CAP | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma;Lymphoma, Mantle-Cell;Myelodysplastic Syndromes | Bristol-MyersSquibbCompany |
| USA | (L04AX04) lenalidomide (adm: O) | REVLIMID 2.5MG CAP | 100 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma;Lymphoma, Mantle-Cell;Myelodysplastic Syndromes | Bristol-MyersSquibbCompany |
| USA | (L04AX04) lenalidomide (adm: O) | REVLIMID 2.5MG CAP | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma;Lymphoma, Mantle-Cell;Myelodysplastic Syndromes | Bristol-MyersSquibbCompany |
Pages
